Bioventus Inc. (BVS) — Shareholders' Equity
| Fiscal Year | Shareholders' Equity | Change YoY |
|---|---|---|
| 2025 | $184.10M | +24.4% |
| 2024 | $147.94M | -14.8% |
| 2023 | $173.59M | -46.6% |
| 2022 | $325.24M | -29.1% |
| 2021 | $458.92M | — |
| Fiscal Year | Shareholders' Equity | Change YoY |
|---|---|---|
| 2025 | $184.10M | +24.4% |
| 2024 | $147.94M | -14.8% |
| 2023 | $173.59M | -46.6% |
| 2022 | $325.24M | -29.1% |
| 2021 | $458.92M | — |